ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $45,000 | -4.3% | 13,000 | 0.0% | 0.01% | -15.4% |
Q3 2021 | $47,000 | -17.5% | 13,000 | 0.0% | 0.01% | -13.3% |
Q2 2021 | $57,000 | -6.6% | 13,000 | -18.8% | 0.02% | -16.7% |
Q4 2020 | $61,000 | +19.6% | 16,000 | 0.0% | 0.02% | +5.9% |
Q3 2020 | $51,000 | +15.9% | 16,000 | 0.0% | 0.02% | +6.2% |
Q2 2020 | $44,000 | -33.3% | 16,000 | -33.3% | 0.02% | -38.5% |
Q1 2020 | $66,000 | -31.2% | 24,000 | 0.0% | 0.03% | -13.3% |
Q4 2019 | $96,000 | -15.8% | 24,000 | -29.4% | 0.03% | -23.1% |
Q3 2019 | $114,000 | +10.7% | 34,000 | 0.0% | 0.04% | +5.4% |
Q1 2019 | $103,000 | +12.0% | 34,000 | 0.0% | 0.04% | +5.7% |
Q4 2018 | $92,000 | -19.3% | 34,000 | 0.0% | 0.04% | +34.6% |
Q3 2018 | $114,000 | +29.5% | 34,000 | 0.0% | 0.03% | +23.8% |
Q2 2018 | $88,000 | +17.3% | 34,000 | 0.0% | 0.02% | +16.7% |
Q1 2018 | $75,000 | +10.3% | 34,000 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $68,000 | -38.2% | 34,000 | 0.0% | 0.02% | -35.7% |
Q3 2017 | $110,000 | – | 34,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |